Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial
Mayo Clinic
Mayo Clinic
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
National Cancer Institute (NCI)
University of Michigan Rogel Cancer Center
Hospital Universitari de Bellvitge
Ohio State University Comprehensive Cancer Center
University of California, San Francisco
University of Washington
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
NRG Oncology
Roswell Park Cancer Institute
Children's Oncology Group
University of California, San Francisco
Mayo Clinic
Wake Forest University Health Sciences
University of Washington
University of Washington
Children's Oncology Group
University of Washington
Roswell Park Cancer Institute
NRG Oncology
University of California, San Francisco
Vanderbilt-Ingram Cancer Center
Jonsson Comprehensive Cancer Center
Mayo Clinic
Ohio State University Comprehensive Cancer Center
OHSU Knight Cancer Institute
Emory University
SWOG Cancer Research Network
Jonsson Comprehensive Cancer Center
SWOG Cancer Research Network
City of Hope Medical Center
City of Hope Medical Center
Jonsson Comprehensive Cancer Center
Children's Oncology Group
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
City of Hope Medical Center
Northwestern University